Supply report · October 2026 register copy
Digestive Health in Nigeria: the registration data
Across the 7 digestive health molecules Ogbogwu tracks, our October 2026 copy of the NAFDAC Greenbook lists 162 active registrations held by 106 companies — plus 233 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 162
- Companies
- 106
- New in the last 12 months
- 6
- Renewals due within a year
- 31
Who holds the registrations
The ten companies with the most active digestive health registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Fidson Healthcare— 5 active
- 2.Me Cure Industries— 5 active
- 3.Getz Pharma Nigeria— 4 active
- 4.Greenlife Pharmaceutical— 4 active
- 5.Krishat Pharma Industries— 4 active
- 6.Alben Health Care Industries— 3 active
- 7.Aphantee Pharma Nigeria— 3 active
- 8.DannyFaith Pharmacy— 3 active
- 9.Emzor Pharmaceutical Industries— 3 active
- 10.Sagar Vitaceuticals Nigeria— 3 active
Where the products are made
Maker country as the register records it, across the 162 active registrations (1 rows carry no country in our copy).
- India— 80 (49%)
- Nigeria— 52 (32%)
- China— 21 (13%)
- Pakistan— 5 (3%)
- Malaysia— 1 (1%)
- Portugal— 1 (1%)
- Sweden— 1 (1%)
Dosage forms
- Capsule— 63 active
- Tablet— 40 active
- Suspension— 17 active
- Powder for injection— 15 active
- Chewable tablet— 5 active
- Caplet— 4 active
- Injection— 4 active
- Kit— 3 active
Newest registrations
The latest digestive health approvals in our copy — 6 products were registered in the twelve months to October 2026.
- Animotil Tablets — A4-7602, approved 2025-11-26
- NAZA Omeprazole 40mg for Injection with Sodium Chloride Injection BP 10 mL — A4-101686, approved 2025-11-26
- Modia Loperamide 2 mg Capsules — A4-101597, approved 2025-10-29
- Modia Loperamide 2 mg Orodispersible Tablets — A4-101598, approved 2025-10-29
- Loperamide Hydrochloride BP Capsules 2 mg — A4-101671, approved 2025-10-29
31 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Omeprazole — 63 active registrations
- Loperamide — 29 active registrations
- Cimetidine — 23 active registrations
- Esomeprazole — 8 active registrations
- Hyoscine Butylbromide — 8 active registrations
- Oral Rehydration Salts (ORS) — 3 active registrations
- Magnesium Trisilicate (Compound Antacid) — 1 active registrations
“Digestive Health” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Omeprazole 20 mg capsule — 40 companies
- Loperamide 2 mg capsule — 19 companies
- Omeprazole 40 mg powder for injection — 15 companies
- Loperamide 2 mg tablet — 9 companies
- Cimetidine 400 mg tablet — 8 companies
- Cimetidine 200 mg tablet — 7 companies
Manufacturing or exporting digestive health medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.